Skip to content
Tenfell
Awarded contract
Published 26 Sep 2019

NHS National Pharmaceuticals Transition 2019_1 - Contracts Finder Award Notice

NHS England · London

Key facts

Contract value
£28,656,720
Awarded
01 Aug 2019
Contract starts
30 Sep 2019
Contract ends
28 Feb 2021
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to

SupplierValue
Please see list of awarded suppliers (including SME status) at t£28,656,720

Description

NHS National Pharmaceuticals Transition 2019_1 Offer reference number: CM/PHG/17/5547 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 34 months Potential periods of call-offs under the framework agreement: LSNE: 01/10/2019 to 30/04/2020 (7 months) CESW: 01/10/2019 to 30/09/2020 (12 months) NWLN: 01/10/2019 to 28/02/2021 (17 months)

Awarded product list bortezomib, arsenic, darunavir, atazanavir, ritonavir, miglustat, gefitinib, carglumic acid, clofaribine, ganciclovir, aprepitant, dexmedetomidine, solifenacin, atomoxetine, atovaquone, metaraminol and olopatadine

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.